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OBJECTIVES The aim of the study was to assess the hemodynamic status of survivors of out-of-hospital
cardiac arrest (OHCA).
BACKGROUND The global prognosis after successfully resuscitated patients with OHCA remains poor.
Clinical studies describing the hemodynamic status of survivors of OHCA and its impact on
prognosis are lacking.
METHODS Among 165 consecutive patients admitted after successful resuscitation from OHCA, 73
required invasive monitoring because of hemodynamic instability, defined as hypotension
requiring vasoactive drugs, during the first 72 h. Clinical features and data from invasive
monitoring were analyzed.
RESULTS Hemodynamic instability occurred at a median time of 6.8 h (range 4.3 to 7.3) after OHCA.
The initial cardiac index (CI) and filling pressures were low. Then, the CI rapidly increased
24 h after the onset of OHCA, independent of filling pressures and inotropic agents (2.05
[1.43 to 2.90] 8 h vs. 3.19 l/min per m2 [2.67 to 4.20] 24 h after OHCA; p 0.001). Despite
a significant improvement in CI at 24 h, a superimposed vasodilation delayed the
discontinuation of vasoactive drugs. No improvement in CI at 24 h was noted in 14 patients
who subsequently died of multiorgan failure. Hemodynamic status was not predictive of the
neurologic outcome.
CONCLUSIONS In survivors of OHCA, hemodynamic instability requiring administration of vasoactive drugs
is frequent and appears several hours after hospital admission. It is characterized by a low CI
that is reversible in most cases within 24 h, suggesting post-resuscitation myocardial
dysfunction. Early death by multiorgan failure is associated with a persistent low CI at 24 h.
(J Am Coll Cardiol 2002;40:2110–6) © 2002 by the American College of Cardiology
Foundation
Despite community-based interventions, survival after out-
of-hospital cardiac arrest (OHCA) remains low. Less than
30% of cardiopulmonary resuscitation (CPR) attempts
started out of hospitals lead to restoration of spontaneous
circulation and to hospital admission (1). In-hospital treat-
ment of comatose survivors of cardiac arrest is usually
supportive, and hospital mortality is as high as 70% (2,3).
Late mortality and morbidity are due to post-anoxic neu-
rologic consequences, with 10% to 40% of survivors sustain-
ing significant permanent brain damage (1–4). In contrast,
early death is often due to persistent hemodynamic insta-
bility leading to multiple organ failure (1). Animal studies
support the concept that post-resuscitation hemodynamic
instability is related to acute myocardial dysfunction. In
animal models, post-resuscitation myocardial dysfunction is
characterized by impaired contractile function, decreased
work capacity, and variable diastolic dysfunction that re-
verses several hours or days after resuscitation (5–7).
Few studies have investigated post-resuscitation hemody-
namic instability and myocardial dysfunction in humans
(8,9). To address this issue, hemodynamic data during the
first 72 h after arrest were prospectively gathered in a
consecutive series of 165 patients included in a study on the
value of immediate coronary angiography followed, if nec-
essary, by angioplasty after successful resuscitation from
OHCA (10). The prevalence, risk factors, and evolution of
post-resuscitation hemodynamic instability and myocardial
dysfunction, as well as their influence on survival with or
without neurologic damage, were assessed.
METHODS
Patient selection. In Paris, management of OHCA in-
volves emergency units equipped with ambulances that are
always staffed by one or two physicians trained in emergency
medicine. In cases of sudden OHCA, CPR was initiated
according to standard procedures. Successfully resuscitated
patients were included in a prospective study on the value of
immediate coronary angiography followed, if necessary, by
coronary angioplasty, if they were between 30 and 75 years
old, if sudden cardiac arrest occurred within 6 h of the onset
of symptoms in patients who were previously leading a
normal life, and if there was no obvious noncardiac cause of
cardiac arrest.
Patients who met the criteria were brought directly to the
cardiac catheterization laboratory of our hospital, and im-
mediate coronary and left ventricular angiography was
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performed according to standard techniques. If a recent
coronary artery occlusion was found, coronary angioplasty
was attempted, unless the infarct-related vessel was too
small or the operator considered the procedure to be
technically impossible. Standard resuscitation and stabiliza-
tion procedures were continued during the procedure. The
patients were then transported to the medical intensive care
unit for supportive treatment, including mechanical venti-
lation. Hypotension, defined as a mean arterial blood
pressure 75 mm Hg, was treated according to the follow-
ing protocol: 1) volume expansion was determined by the
left ventricular end-diastolic pressure (LVEDP) measured
before left ventricular angiography: volume expansion con-
sisted of 1,000 ml of crystalloids if LVEDP was 18 mm
Hg or 500 ml if LVEDP was between 18 and 25 mm Hg;
the administration was repeated twice if there was no
evidence of pulmonary congestion; and 2) vasoactive drug
infusion was initiated if hypotension was unresponsive to
volume challenge or when there was no previous volume
expansion if LVEDP was 25 mm Hg and/or if clinical or
radiologic signs of pulmonary edema were noted. Hemody-
namic instability was defined as the need for vasoactive
drugs, leading to invasive monitoring by an arterial pressure
and pulmonary artery catheter that was performed as soon as
possible after the onset of vasoactive drug therapy. Shock
was defined by the association between hypotension unre-
sponsive to vasoactive drug infusion and evidence of inad-
equate organ perfusion revealed by elevated plasma lactate
concentrations, metabolic acidosis, or oliguria (50 ml/h).
Invasive monitoring. A 7F pulmonary artery catheter
(Baxter-Edwards, Irvine, California) was inserted through
the central port of an introducer in a central vein (internal
jugular or subclavian vein) and guided by pressure wave-
forms into a branch of a pulmonary artery. The right
position in West’s third zone was systematically controlled
by standard chest radiography. An arterial pressure catheter
(Vygon SA, Ecouen, France) was inserted through a radial
or femoral artery to continuously monitor blood pressure.
Pressure waveforms were recorded on a Hewlett-Packard
monitor (Merlin, Hewlett-Packard, Palo Alto, California).
Cardiac output was determined by thermodilution after
injection of 10 ml of cold isotonic glucose. The cardiac
output values represented the average of three measure-
ments within 20% of each other. Cardiac index (CI) was
obtained by dividing cardiac output by body surface area.
Data collection. The clinical data collected during resus-
citation and hospitalization were prospectively entered in a
computer database described previously (10). Coronary
angiograms underwent final qualitative and quantitative
review. Left ventricular ejection fraction was estimated by
the biplane area–length method, as described by Dodge et
al. (11). The time of the lowest mean arterial pressure
unresponsive to volume expansion, measured by noninvasive
methods, was entered as time 0.
Hemodynamic data provided by invasive monitoring
were reviewed. Measurements performed immediately after
insertion of the pulmonary artery catheter (time 1) were
entered in the data base, as well as measurements obtained
4 (time 2) and 12 h (time 3) after insertion. Finally, a fourth
set of measurements performed 72 h after the onset of
OHCA was included (time 4). If death occurred during the
first 72 h, the final measurements were entered as time 4.
The final neurologic status at hospital discharge was
assessed using the five-point Pittsburgh modification of the
Glasgow outcome categories (1). Cerebral performance
categories (CPCs) are defined as follows: CPC-1  good
cerebral performance; CPC-2  moderate cerebral disabil-
ity; CPC-3 severe cerebral disability; CPC-4 persistent
vegetative state; and CPC-5 brain death or clinical death.
The study protocol was reviewed and approved by the
Ethics Committee of Cochin Hospital. Because informed
consent was impossible to obtain immediately from the
patients, the next of kin provided consent for management,
according to the protocol described previously, and for the
use of data gathered before admission and during the
hospital stay for scientific purposes. Survivors also provided
consent as soon as possible.
Statistical analysis. Because of asymmetric distribution,
continuous variables are reported as median values and
interquartile ranges (25th and 75th percentiles). Discrete
variables are expressed as percentages. Univariate analysis
was performed using the chi-square tests for categorical
variables and the Mann-Whitney U test for numeric data.
Hemodynamic parameter variations were tested using non-
parametric analysis of variance (Kruskall-Wallis test). Post-
hoc comparisons between points in time were performed
using the Wilcoxon matched-pairs, signed, rank-sum test.
Parameters found to be significantly associated with hemo-
dynamic instability on univariate analysis were subsequently
included in a multivariate logistic regression model to test
their independent association. A two-tailed p value 0.05
was considered to indicate statistical significance. All statis-
tical analyses were done on a personal computer using
STATA version 7.0 software (Stata Corp., College Station,
Texas).
RESULTS
Study population. From January 1994 to March 1998,
four emergency units in Paris responded to 2,555 cases of
suspected OHCA. In 1,232 patients, CPR was not at-
tempted because of the medical team’s late arrival or because
the patient had a severe preexisting disease. Resuscitation
was attempted in the remaining 1,323 patients (52%), and a
Abbreviations and Acronyms
CI  cardiac index
CPC  cerebral performance category
CPR  cardiopulmonary resuscitation
LVEDP  left ventricular end-diastolic pressure
OHCA  out-of-hospital cardiac arrest
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stable hemodynamic state was obtained in 458 (18%). Fatal
recurrent cardiac arrest occurred during transportation in
182 patients: the terminal rhythm was asystole in 164 and
electromechanical dissociation in 18. So, 276 patients (11%)
were successfully transported. A total of 111 patients were
excluded from the study either because they had an obvious
noncardiac cause of cardiac arrest (n  66) or because they
were outside of the age range for the study. Therefore, 165
patients (6.5%) were included. Immediate coronary angiog-
raphy was attempted in all patients; it was impossible to
perform in one because of extensive peripheral artery dis-
ease. Follow-up was then performed in the intensive care
unit. Hemodynamic instability requiring vasoactive drugs
occurred in 90 patients (54.5%) during the first 72 h after
resuscitation. Invasive monitoring was considered to be
futile for 17 moribund patients. Therefore, 73 patients were
effectively monitored invasively for hemodynamic instability
(group A), and 75 patients did not develop hemodynamic
instability during follow-up (group B).
Risk factors for hemodynamic instability after resuscita-
tion. Patient characteristics are summarized in Table 1.
The interval between the onset of arrest and the return of
spontaneous circulation was significantly longer in group A
patients (25 [14 to 38] vs. 15 min [7 to 30], p  0.01). The
dose of epinephrine received during CPR was higher in
patients with hemodynamic instability (10 [3 to 15] vs. 2.0
mg [0 to 10], p  0.01). Similarly, there were more
countershocks in group A patients than in group B patients
(3 [1 to 6] vs. 2 [1 to 3], p  0.01). Hemodynamic data
gathered during the angiographic procedure showed signif-
icant differences between the groups: the left ventricular
ejection fraction was decreased in both groups, but signifi-
cantly lower in group A (32% [25 to 40%] vs. 43% [35 to
50%] in group B, p  0.01), and LVEDP was higher in
group A (18.5 [10 to 32] vs. 12.1 [5 to 25] mm Hg in group
B, p  0.01). A trend toward a higher incidence of
post-resuscitation hemodynamic instability was noted if
acute coronary occlusion was the cause of OHCA (50.7%
vs. 37.3%, p  0.06). On multivariate analysis, the dose of
epinephrine received during CPR was the only predictive
factor of hemodynamic instability (odds ratio 1.05 per mg of
epinephrine received during CPR, 95% confidence interval
1.01 to 1.11; p  0.035).
Hemodynamic profile and renal and hepatic variables in
patients with hemodynamic instability. Hemodynamic
data are summarized in Table 2. The onset of hemodynamic
instability was most often delayed after admission to the
intensive care unit. A significant decrease in mean arterial
pressure unresponsive to volume expansion was noted 6.8 h
(range 4.3 to 7.3) after OHCA (time 0) and led to infusion
of vasoactive drugs and invasive monitoring by a pulmonary
artery catheter 8 h (range 7 to 9) (time 1) after cardiac arrest
(mean arterial pressure at admission in intensive care unit:
87 [75 to 103] vs. 62 [46 to 71] mm Hg at time 0; p 
0.01). Hemodynamic data recorded at time 1 revealed a low
CI (2.05 l/min per m2 [range 1.43 to 2.90]), which
Table 1. Patient Characteristics
Characteristics
Group A:
Hemodynamic
Instability (n  73)
Group B:
No Hemodynamic
Instability (n  75) p Value
Age (years) 57 (49–65) 56 (43–64) 0.31
Male gender 57 (78%) 67 (89%) 0.09
History of CAD 17 (23%) 16 (21%) 0.76
Intervals
Onset of arrest to initial CPR (min) 5 (1–10) 5 (2–9) 0.59
Onset of arrest to ROSC (min) 25 (14–38) 15 (7–30)  0.01
VF recorded as initial cardiac rhythm 51 (70%) 50 (66%) 0.75
Number of countershocks 3 (1–6) 2 (1–3)  0.01
Total dose of epinephrine during CPR (mg) 10 (3–15) 2 (0–10)  0.01
Perfusion of epinephrine required
Maximal perfusion rate during first day (mg/h) 2 (0–3) 0  0.01
Duration of treatment (days) 2 (1–4) 0  0.01
Angiographic data
Heart rate (beats/min) 105 (75–143) 85 (48–118)  0.05
MAP (mm Hg) 95 (85–105) 98 (91–110) 0.85
LVEDP (mm Hg) 18.5 (10–32) 12.1 (5–25)  0.01
LVEF (%) 32 (25–40) 43 (35–50)  0.01
Significant CAD 54 (74%) 53 (71%) 0.98
Single-vessel disease 26 (48%) 26 (49%)
Two- or three-vessel disease 28 (52%) 27 (51%)
Recent coronary artery occlusion 37 (50.7%) 28 (37.3%) 0.06
Angioplasty attempted 31 (83.7%) 25 (89.2%) 0.45
Angioplasty successful 23 (74.1%) 19 (76%) 0.29
Data are presented as the median value (interquartile range) or number (%) of patients.
CAD  coronary artery disease; CPR  cardiopulmonary resuscitation; LVEDP  left ventricular end-diastolic pressure;
LVEF  left ventricular ejection fraction; MAP  mean arterial pressure; PTCA  percutaneous transluminal coronary
angioplasty; ROSC  return of spontaneous circulation; VF  ventricular fibrillation.
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improved linearly through time (Kruskall-Wallis test: p 
0.001). An alteration of CI was associated with normal or
low filling pressures that required a median of 8,000 ml
(range 7,500 to 9,000) of volume expansion to keep the
patient stable during the first 72 h. After a further decrease
in mean arterial pressure, despite initiation of dobutamine
or epinephrine, systemic hypotension began to improve
progressively, allowing, in most cases, discontinuation of
vasopressor treatment within 72 h.
Renal and hepatic variables recorded at 24 h are summa-
rized in Table 3. Significant increases in plasma creatinine
and diuresis and a decrease in the International Normalized
Ratio were noted in group A.
Fourteen patients from group A (19.2%) died of shock
during the early phase. Their hemodynamic status differed
markedly from that of the other patients (Table 4). Invasive
monitoring showed a low CI, which did not improve
significantly (Kruskall-Wallis test: p  0.40), despite in-
creased doses of epinephrine. This difference appears at time
2 and becomes significant at time 3.
In-hospital mortality and neurologic outcome. Of the 73
patients who required hemodynamic monitoring, 28 had a
favorable in-hospital outcome, as hemodynamic instability
was reversible and neurologic sequelae were absent or
minimal (i.e., CPC-1 or CPC-2 at hospital discharge).
Fourteen patients died of shock, and 31 developed transient
hemodynamic instability but had major post-anoxic brain
damage: 4 had severe cerebral disability (CPC-3), 21
remained in a persistent vegetative state (CPC-4), and 6 had
brain death. There was no difference in the neurologic
outcome between patients with hemodynamic instability
and the other patients (42.4% in group A vs. 44% in group
B with severe brain damage, p  0.54).
DISCUSSION
After successful resuscitation from cardiac arrest, patients
admitted to intensive care units often develop multiorgan
failure leading to death during the first three days (2,3). In
contrast, late mortality is directly related to neurologic
damage, with 50% of patients remaining in a vegetative
state (4). The present report is the first clinical study to
elucidate the hemodynamic status of survivors of CPR:
hemodynamic instability requiring the administration of
vasoactive agents was noted in more than half of survivors
after successful CPR. The onset of hemodynamic instability
onset was delayed 4 to 7 h after admission, and full recovery
was seen in survivors by 72 h. Early death by multiorgan
failure was associated with a persistent low CI at 24 h.
Hemodynamic status was not predictive of the neurologic
outcome.
Risk factors for hemodynamic instability after cardiac
arrest. On multivariate analysis, the amount of epinephrine
used during CPR predicted the occurrence of hemodynamic
instability. Our results confirm experimental data that sug-
gest that epinephrine potentiates myocardial dysfunctionTa
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after resuscitation (12). Previous clinical studies suggest that
high doses of epinephrine given during resuscitation may
alter the CI after return of spontaneous circulation and
could be an independent predictor of mortality (9,13).
In contrast, the duration of CPR predicted the occurrence
of hemodynamic instability by univariate, but not multivar-
iate, analysis. According to our resuscitation procedures, the
amount of epinephrine used increased with the CPR dura-
tion. This factor may have influenced our multivariate
analysis, which was performed in a relatively small number
of patients. Therefore, a relationship between CPR duration
and hemodynamic instability cannot be excluded.
A trend toward a higher rate of post-resuscitation hemo-
dynamic instability was noted if acute coronary occlusion
was the cause of OHCA (50.7% vs. 37.3%, p  0.06).
Global post-resuscitation myocardial stunning may prevent
acute compensatory mechanisms during OHCA due to
myocardial infarction, such as hyperkinesia of noninfarcted
left ventricular segments, thereby potentiating refractory
shock and multiorgan failure. In our study, successful
angioplasty was always performed within 3 h after the onset
of cardiac arrest. Angioplasty failure occurred in eight
patients; 5 died of refractory shock. In contrast, a 13.5%
mortality rate from refractory shock was noted after success-
ful angioplasty, which compares favorably to the 19.1%
mortality rate from refractory shock in patients without
acute myocardial infarction. Therefore, a favorable hemo-
dynamic effect of successful angioplasty cannot be excluded.
In contrast, no relationship was found between the extent of
coronary disease and the occurrence of shock. The amount
of ischemic damage occurring during cardiac arrest and
resuscitation may therefore be so substantial that even the
myocardium fed by normal coronary arteries is severely
affected. Severe myocardial dysfunction can therefore occur
after cardiac arrest, independent of severe underlying coro-
nary disease.
Evidence for post– cardiac arrest myocardial stun-
ning. Our data suggest that myocardial stunning is an
important cause of post-resuscitation shock. The left ven-
tricular ejection fraction was severely depressed at hospital
admission. The time course of post-resuscitation shock in
our study showed marked depression of the CI at 8 h after
arrest and a return to normal values within 24 h, with
discontinuation of inotropic support at 72 h after the onset
of cardiac arrest in survivors. Other common causes of acute
myocardial dysfunction, such as hypoxia and hypercapnia,
were ruled out by monitoring oxygen transport during the
post-resuscitation period. Furthermore, immediate coronary
angiography was performed in all patients at admission, and
severe but transient myocardial dysfunction was observed in
36 group A patients (49.3%) with no acute coronary
occlusion. The characteristics of the myocardial dysfunction
Table 3. Renal and Hepatic Variables at 24 Hours
Characteristics
Group A:
Hemodynamic Instability
Group B:
No Hemodynamic Instability p Value
Plasma urea (mmol/l) 8.3 (6.7–11.3) 7.6 (6.2–8.8) 0.03
Plasma creatinine (mol/l) 153 (121–184) 111 (98–128) 0.0001
Diuresis (l/24 h) 1.0 (0.3–1.9) 1.5 (1.1–2.4) 0.001
Plasma total bilirubin (mol/l) 11 (8–14) 10 (7–13) 0.28
INR 1.3 (1.0–1.8) 1.0 (0.9–1.4) 0.001
Data are presented as the median value (interquartile range).
INR  International Normalized Ratio.
Table 4. Evolution of Cardiac Index, Mean Arterial Pressure, and Epinephrine Requirements Through Time According to Prognosis
Admission Time 1 Time 2 Time 3 Time 4
Hemodynamic instability, good neurologic outcome
(n  28)
CI (l/min per m2) — 2.13 (1.40–2.81) 3.01 (2.22–3.64) 3.35 (3.12–4.33) 3.86 (2.92–4.31)
MAP (mm Hg) 83 (69–104) 75 (67–89) 75 (69–83) 80 (74–86) 82 (74–95)
Epinephrine perfusion (mg/h) 0 0.5 (0–2.0) 0.75 (0–2.0) 1 (0–2.0) 0 (0–1.0)
C[av]O2 (ml/dl) — 6.5 (4.59–8.84) 4.71 (3.48–5.90) 3.81 (3.23–5.04) 3.43 (2.71–4.70)
Hemodynamic instability, poor neurologic outcome
(n  31)
CI (l/min per m2) — 2.04 (1.41–2.89) 2.44 (1.86–3.17) 3.10 (2.70–4.25) 3.76 (3.26–4.79)
MAP (mm Hg) 86 (77–103) 89 (77–110) 81 (70–90) 78 (70–91) 80 (74–87)
Epinephrine infusion (mg/h) 0 1.0 (0–3.0) 1.0 (0–2.0) 1.0 (0–2.7) 0.5 (0–1.5)
C[av]O2 (ml/dl) — 5.80 (4.45–7.37) 5.16 (3.38–6.39) 3.89 (3.44–4.47) 4.00 (3.27–4.56)
Shock leading to death (n  14)
CI (l/min per m2) — 2.37 (1.26–3.83) 2.39 (1.88–2.80) 2.56 (2.27–2.98)† 2.90 (2.15–3.57)*
MAP (mm Hg) 89 (77–108) 85 (62–103) 74 (66–91) 76 (65–84) 73 (68–75)*
Epinephrine perfusion (mg/h) 0 2.0 (0–3.1) 2.0 (0.5–8.0) 3.0 (1.2–8.2)* 2.0 (1.0–8.0)†
C[av]O2 (ml/dl) — 5.23 (2.92–8.22) 5.44 (4.08–7.25) 4.66 (4.32–5.69)† 4.71 (3.88–5.54)*
*p  0.05, †p  0.01, ‡p  0.001 for all tests performed versus baseline. Data are presented as the median value (interquartile range).
C[av]O2  oxygen content difference between arterial and mixed venous blood; CI  cardiac index; MAP  mean arterial pressure.
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observed in our patients are similar to those in previously
published experimental reports (5,6). Gazmuri et al. (5)
reported post-resuscitation myocardial dysfunction by using
a model of ventricular fibrillation in pigs. Progressive
impairment in contractile function with ventricular dilation
was detected early after resuscitation and was maximal at
6 h. Kern et al. (6) studied, using both invasive and
noninvasive measurements of left ventricular function, 23
domestic swine successfully resuscitated after 10 or 15 min
of untreated cardiac arrest. Severe myocardial systolic and
diastolic left ventricular dysfunction was documented and
peaked at 2 to 5 h after resuscitation, despite the return of
myocardial blood flow to normal levels. Full recovery of this
post-resuscitation myocardial dysfunction was seen after
48 h.
Superimposed vasodilation. Despite rapid improvement
in CI in our patients, hemodynamic instability worsened
(mean arterial pressure: 79 mm Hg [69 to 102] at 8 h and
76 mm Hg [69 to 87] at 12 h, p  0.01; epinephrine
perfusion: 1.0 mg/h [0 to 2.2] at 8 h and 1.3 mg/h [0 to 2.0]
at 12 h, p 0.05). Discontinuation of vasopressor drugs was
therefore delayed despite improvement of CI. A large
volume expansion was initially required (cumulative crystal-
loid volume infused: 5,000 [3,500 to 6,500] ml at 24 h;
8,000 ml [7,500 to 9,500] at time 4) to maintain filling
pressures 12 mm Hg and resulted in hemodilution at day
3 (hemoglobin: 9.8 g/100 ml at day 3 [9.0 to 11.5] vs. 14.6
g/100 ml [13.4 to 15.8] at admission; p  0.001). There-
fore, our data suggest that vasodilation occurred during the
first two days after CPR. Further studies are needed to
confirm these preliminary results and to characterize the role
of each component of post-resuscitation hemodynamic
instability. Of particular interest, post-CPR vasodilation has
not been clearly identified in animal studies.
Hemodynamic status and neurologic outcome. In con-
trast to previous experimental data, no relationship between
the occurrence and pattern of post-resuscitation hemody-
namic instability and neurologic outcome was noted (7). We
suggest that aggressive treatment of hemodynamic instabil-
ity in selected cases is justified during the first days after
cardiac arrest, until reliable assessment of the neurologic
prognosis can be performed.
Study limitations. Vasoactive drugs and hemodynamic
monitoring were started in survivors of OHCA with hemo-
dynamic instability, defined by a mean arterial pressure75
mm Hg and unresponsiveness to volume expansion. Pa-
tients were treated with vasoactive drugs before the occur-
rence of clinical signs of shock, such as cool extremities,
tachycardia, or a decreased urine output. Precise definitions
of hemodynamic instability or shock in this setting are
lacking; however, close monitoring of blood pressure and
administration of vasoactive drugs are recommended (14).
Furthermore, variations of renal and hepatic variables were
noted at 24 h in patients with hemodynamic instability,
thereby suggesting extensive systemic hypoperfusion.
Hemodynamic monitoring was only performed in pa-
tients who developed hemodynamic instability after cardiac
arrest. A severe alteration in left ventricular ejection fraction
was also observed initially in group B (43.0% [35% to 50%]),
suggesting that transient myocardial dysfunction was
present in all patients, but clinically relevant in selected
cases. Serial studies of left ventricular function using non-
invasive techniques, such as echocardiography, in all survi-
vors of OHCA would allow a more accurate evaluation of
post-resuscitation myocardial dysfunction.
Patients with a noncardiac cause of arrest were excluded
from the study; therefore, the conclusions of our study
cannot be applied to all survivors of OHCA.
Conclusions. In survivors of OHCA, hemodynamic insta-
bility leading to the administration of vasoactive drugs is
frequent and appears 4 to 7 h after hospital admission. It is
associated with the use of high doses of epinephrine during
CPR. Post-resuscitation hemodynamic instability is charac-
terized by a low CI and normal or low filling pressures. The
CI rapidly increases 24 h after the onset of OHCA,
independent of filling pressures and vasoactive agents. A
superimposed vasodilation requires a large initial volume
expansion and delays the discontinuation of vasopressor
drugs. Recovery is most often obtained within three days.
This unique hemodynamic profile is suggestive of post-
resuscitation myocardial stunning associated with vasodila-
tion. Hemodynamic status did not predict the final neuro-
logic outcome. Aggressive management of post-
resuscitation hemodynamic instability therefore seems
justified until accurate prediction of the neurologic outcome
is feasible.
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